APO Research
Talk to an analyst

APO RESEARCH · REPORT

Factor IX Complex Drug

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Factor IX Complex Drug Market Outlook and Growth Opportunities 2026

21 December 2025194 pages

Choose your research edition.

Industry ResearchFactor IX Complex Drug Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Factor IX Complex Drug Industry Growth and Trends Forecast to 203298 pages · $3,450 USDMarket StructureGlobal Factor IX Complex Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Factor IX Complex Drug Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Factor IX Complex Drug Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Factor IX Complex Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Factor IX Complex Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Factor IX Complex Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Factor IX Complex Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Factor IX Complex Drug market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Factor IX Complex Drug market include Takeda, Grifols, Prothya Biosolutions, Octapharma and CSL Behring, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Factor IX Complex Drug market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Factor IX Complex Drug and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Factor IX Complex Drug sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Factor IX Complex Drug market size, projected growth trends, production technologies, key applications, and end-use industries.

Factor IX Complex Drug Segment by Company

Takeda

Grifols

Prothya Biosolutions

Octapharma

CSL Behring

Factor IX Complex Drug Segment by Type

Prothromplex

Profilnine

Octaplex

Cofact

Beriplex

Other

Factor IX Complex Drug Segment by Application

Hemophilia B

Acquired Coagulation Factor Deficiency

Factor IX Complex Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Factor IX Complex Drug status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Factor IX Complex Drug market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Factor IX Complex Drug significant trends, drivers, influence factors in global and regions.

6. To analyze Factor IX Complex Drug competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Factor IX Complex Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Factor IX Complex Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Factor IX Complex Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Factor IX Complex Drug market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Factor IX Complex Drug industry.

Chapter 3: Detailed analysis of Factor IX Complex Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Factor IX Complex Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Factor IX Complex Drug in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Factor IX Complex Drug Industry Trends Table 2. Factor IX Complex Drug Industry Drivers Table 3. Factor IX Complex Drug Industry Opportunities and Challenges Table 4. Factor IX Complex Drug Industry Restraints Table 5. Global Factor IX Complex Drug Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Factor IX Complex Drug Revenue Share by Company (2021-2026) Table 7. Global Factor IX Complex Drug Sales Volume by Company (k units) & (2021-2026) Table 8. Global Factor IX Complex Drug Sales Volume Share by Company (2021-2026) Table 9. Global Factor IX Complex Drug Average Price (US$/unit) of Company (2021-2026) Table 10. Global Factor IX Complex Drug Company Ranking, (2024-2026) & (USD Million) Table 11. Global Factor IX Complex Drug Key Company Manufacturing Base & Headquarters Table 12. Global Factor IX Complex Drug Company, Product Type & Application Table 13. Global Factor IX Complex Drug Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Factor IX Complex Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Prothromplex Table 18. Significant Companies of Profilnine Table 19. Significant Companies of Octaplex Table 20. Significant Companies of Cofact Table 21. Significant Companies of Beriplex Table 22. Significant Companies of Other Table 23. Global Factor IX Complex Drug Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 24. Global Factor IX Complex Drug Sales Volume by Type (2021-2026) & (k units) Table 25. Global Factor IX Complex Drug Sales Volume by Type (2027-2032) & (k units) Table 26. Global Factor IX Complex Drug Sales Volume Share by Type (2021-2026) Table 27. Global Factor IX Complex Drug Sales Volume Share by Type (2027-2032) Table 28. Global Factor IX Complex Drug Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Factor IX Complex Drug Sales Value by Type (2021-2026) & (US$ Million) Table 30. Global Factor IX Complex Drug Sales Value by Type (2027-2032) & (US$ Million) Table 31. Global Factor IX Complex Drug Sales Value Share by Type (2021-2026) Table 32. Global Factor IX Complex Drug Sales Value Share by Type (2027-2032) Table 33. Significant Companies of Hemophilia B Table 34. Significant Companies of Acquired Coagulation Factor Deficiency Table 35. Global Factor IX Complex Drug Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 36. Global Factor IX Complex Drug Sales Volume by Application (2021-2026) & (k units) Table 37. Global Factor IX Complex Drug Sales Volume by Application (2027-2032) & (k units) Table 38. Global Factor IX Complex Drug Sales Volume Share by Application (2021-2026) Table 39. Global Factor IX Complex Drug Sales Volume Share by Application (2027-2032) Table 40. Global Factor IX Complex Drug Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 41. Global Factor IX Complex Drug Sales Value by Application (2021-2026) & (US$ Million) Table 42. Global Factor IX Complex Drug Sales Value by Application (2027-2032) & (US$ Million) Table 43. Global Factor IX Complex Drug Sales Value Share by Application (2021-2026) Table 44. Global Factor IX Complex Drug Sales Value Share by Application (2027-2032) Table 45. Global Factor IX Complex Drug Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 46. Global Factor IX Complex Drug Sales by Region (2021-2026) & (k units) Table 47. Global Factor IX Complex Drug Sales Market Share by Region (2021-2026) Table 48. Global Factor IX Complex Drug Sales by Region (2027-2032) & (k units) Table 49. Global Factor IX Complex Drug Sales Market Share by Region (2027-2032) Table 50. Global Factor IX Complex Drug Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Factor IX Complex Drug Sales Value by Region (2021-2026) & (US$ Million) Table 52. Global Factor IX Complex Drug Sales Value Share by Region (2021-2026) Table 53. Global Factor IX Complex Drug Sales Value by Region (2027-2032) & (US$ Million) Table 54. Global Factor IX Complex Drug Sales Value Share by Region (2027-2032) Table 55. Global Factor IX Complex Drug Market Average Price (US$/unit) by Region (2021-2026) Table 56. Global Factor IX Complex Drug Market Average Price (US$/unit) by Region (2027-2032) Table 57. Global Factor IX Complex Drug Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 58. Global Factor IX Complex Drug Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Factor IX Complex Drug Sales by Country (2021-2026) & (k units) Table 60. Global Factor IX Complex Drug Sales Market Share by Country (2021-2026) Table 61. Global Factor IX Complex Drug Sales by Country (2027-2032) & (k units) Table 62. Global Factor IX Complex Drug Sales Market Share by Country (2027-2032) Table 63. Global Factor IX Complex Drug Sales Value by Country (2021-2026) & (US$ Million) Table 64. Global Factor IX Complex Drug Sales Value Market Share by Country (2021-2026) Table 65. Global Factor IX Complex Drug Sales Value by Country (2027-2032) & (US$ Million) Table 66. Global Factor IX Complex Drug Sales Value Market Share by Country (2027-2032) Table 67. Takeda Company Information Table 68. Takeda Business Overview Table 69. Takeda Factor IX Complex Drug Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 70. Takeda Factor IX Complex Drug Product Portfolio Table 71. Takeda Recent Development Table 72. Grifols Company Information Table 73. Grifols Business Overview Table 74. Grifols Factor IX Complex Drug Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 75. Grifols Factor IX Complex Drug Product Portfolio Table 76. Grifols Recent Development Table 77. Prothya Biosolutions Company Information Table 78. Prothya Biosolutions Business Overview Table 79. Prothya Biosolutions Factor IX Complex Drug Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 80. Prothya Biosolutions Factor IX Complex Drug Product Portfolio Table 81. Prothya Biosolutions Recent Development Table 82. Octapharma Company Information Table 83. Octapharma Business Overview Table 84. Octapharma Factor IX Complex Drug Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 85. Octapharma Factor IX Complex Drug Product Portfolio Table 86. Octapharma Recent Development Table 87. CSL Behring Company Information Table 88. CSL Behring Business Overview Table 89. CSL Behring Factor IX Complex Drug Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 90. CSL Behring Factor IX Complex Drug Product Portfolio Table 91. CSL Behring Recent Development Table 92. Key Raw Materials Table 93. Raw Materials Key Suppliers Table 94. Factor IX Complex Drug Distributors List Table 95. Factor IX Complex Drug Customers List Table 96. Research Programs/Design for This Report Table 97. Authors List of This Report Table 98. Secondary Sources Table 99. Primary Sources List of Figures Figure 1. Factor IX Complex Drug Product Image Figure 2. Global Factor IX Complex Drug Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Factor IX Complex Drug Sales Value (2021-2032) & (US$ Million) Figure 4. Global Factor IX Complex Drug Sales (2021-2032) & (k units) Figure 5. Global Factor IX Complex Drug Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global Factor IX Complex Drug Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Prothromplex Image Figure 10. Profilnine Image Figure 11. Octaplex Image Figure 12. Cofact Image Figure 13. Beriplex Image Figure 14. Other Image Figure 15. Global Factor IX Complex Drug Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 16. Global Factor IX Complex Drug Sales Volume Share 2021 VS 2025 VS 2032 Figure 17. Global Factor IX Complex Drug Sales Volume Share by Type (2021-2032) Figure 18. Global Factor IX Complex Drug Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Factor IX Complex Drug Sales Value Share 2021 VS 2025 VS 2032 Figure 20. Global Factor IX Complex Drug Sales Value Share by Type (2021-2032) Figure 21. Hemophilia B Image Figure 22. Acquired Coagulation Factor Deficiency Image Figure 23. Global Factor IX Complex Drug Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 24. Global Factor IX Complex Drug Sales Volume Share 2021 VS 2025 VS 2032 Figure 25. Global Factor IX Complex Drug Sales Volume Share by Application (2021-2032) Figure 26. Global Factor IX Complex Drug Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Factor IX Complex Drug Sales Value Share 2021 VS 2025 VS 2032 Figure 28. Global Factor IX Complex Drug Sales Value Share by Application (2021-2032) Figure 29. Global Factor IX Complex Drug Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 30. Global Factor IX Complex Drug Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 31. Global Factor IX Complex Drug Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 32. Global Factor IX Complex Drug Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 33. North America Factor IX Complex Drug Sales Value (2021-2032) & (US$ Million) Figure 34. North America Factor IX Complex Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Europe Factor IX Complex Drug Sales Value (2021-2032) & (US$ Million) Figure 36. Europe Factor IX Complex Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Asia-Pacific Factor IX Complex Drug Sales Value (2021-2032) & (US$ Million) Figure 38. Asia-Pacific Factor IX Complex Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 39. South America Factor IX Complex Drug Sales Value (2021-2032) & (US$ Million) Figure 40. South America Factor IX Complex Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 41. Middle East & Africa Factor IX Complex Drug Sales Value (2021-2032) & (US$ Million) Figure 42. Middle East & Africa Factor IX Complex Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 43. USA Factor IX Complex Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. USA Factor IX Complex Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. USA Factor IX Complex Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Canada Factor IX Complex Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Canada Factor IX Complex Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Canada Factor IX Complex Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Mexico Factor IX Complex Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Mexico Factor IX Complex Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Mexico Factor IX Complex Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Germany Factor IX Complex Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Germany Factor IX Complex Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Germany Factor IX Complex Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. France Factor IX Complex Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. France Factor IX Complex Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. France Factor IX Complex Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. U.K. Factor IX Complex Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. U.K. Factor IX Complex Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. U.K. Factor IX Complex Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Italy Factor IX Complex Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Italy Factor IX Complex Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Italy Factor IX Complex Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Spain Factor IX Complex Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Spain Factor IX Complex Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Spain Factor IX Complex Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Russia Factor IX Complex Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Russia Factor IX Complex Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Russia Factor IX Complex Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Netherlands Factor IX Complex Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Netherlands Factor IX Complex Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Netherlands Factor IX Complex Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. Nordic Countries Factor IX Complex Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. Nordic Countries Factor IX Complex Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. Nordic Countries Factor IX Complex Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. China Factor IX Complex Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. China Factor IX Complex Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. China Factor IX Complex Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Japan Factor IX Complex Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Japan Factor IX Complex Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Japan Factor IX Complex Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. South Korea Factor IX Complex Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. South Korea Factor IX Complex Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. South Korea Factor IX Complex Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. India Factor IX Complex Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. India Factor IX Complex Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. India Factor IX Complex Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Australia Factor IX Complex Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Australia Factor IX Complex Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Australia Factor IX Complex Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Southeast Asia Factor IX Complex Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Southeast Asia Factor IX Complex Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Southeast Asia Factor IX Complex Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Brazil Factor IX Complex Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Brazil Factor IX Complex Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Brazil Factor IX Complex Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Argentina Factor IX Complex Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Argentina Factor IX Complex Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Argentina Factor IX Complex Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Chile Factor IX Complex Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Chile Factor IX Complex Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Chile Factor IX Complex Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Colombia Factor IX Complex Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Colombia Factor IX Complex Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Colombia Factor IX Complex Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Peru Factor IX Complex Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Peru Factor IX Complex Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Peru Factor IX Complex Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Factor IX Complex Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Saudi Arabia Factor IX Complex Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Saudi Arabia Factor IX Complex Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Israel Factor IX Complex Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Israel Arabia Factor IX Complex Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Israel Arabia Factor IX Complex Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. UAE Factor IX Complex Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. UAE Factor IX Complex Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. UAE Factor IX Complex Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Turkey Factor IX Complex Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Turkey Factor IX Complex Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Turkey Factor IX Complex Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Iran Factor IX Complex Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Iran Factor IX Complex Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Iran Factor IX Complex Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Egypt Factor IX Complex Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 125. Egypt Factor IX Complex Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 126. Egypt Factor IX Complex Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 127. Factor IX Complex Drug Value Chain Figure 128. Manufacturing Cost Structure Figure 129. Factor IX Complex Drug Sales Mode & Process Figure 130. Direct Comparison with Distribution Share Figure 131. Distributors Profiles Figure 132. Years Considered Figure 133. Research Process Figure 134. Key Executives Interviewed

Scope & coverage.

Types
  • Prothromplex
  • Profilnine
  • Octaplex
  • Cofact
  • Beriplex
  • Other
Applications
  • Hemophilia B
  • Acquired Coagulation Factor Deficiency
Companies covered
  • Takeda
  • Grifols
  • Prothya Biosolutions
  • Octapharma
  • CSL Behring

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Factor IX Complex Drug Sales Value (2021-2032)
  4. 1.2.2 Global Factor IX Complex Drug Sales Volume (2021-2032)
  5. 1.2.3 Global Factor IX Complex Drug Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Factor IX Complex Drug Market Dynamics
  1. 2.1 Factor IX Complex Drug Industry Trends
  2. 2.2 Factor IX Complex Drug Industry Drivers
  3. 2.3 Factor IX Complex Drug Industry Opportunities and Challenges
  4. 2.4 Factor IX Complex Drug Industry Restraints
3 Factor IX Complex Drug Market by Company
  1. 3.1 Global Factor IX Complex Drug Company Revenue Ranking in 2025
  2. 3.2 Global Factor IX Complex Drug Revenue by Company (2021-2026)
  3. 3.3 Global Factor IX Complex Drug Sales Volume by Company (2021-2026)
  4. 3.4 Global Factor IX Complex Drug Average Price by Company (2021-2026)
  5. 3.5 Global Factor IX Complex Drug Company Ranking (2024-2026)
  6. 3.6 Global Factor IX Complex Drug Company Manufacturing Base and Headquarters
  7. 3.7 Global Factor IX Complex Drug Company Product Type and Application
  8. 3.8 Global Factor IX Complex Drug Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Factor IX Complex Drug Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Factor IX Complex Drug Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Factor IX Complex Drug Market by Type
  1. 4.1 Factor IX Complex Drug Type Introduction
  2. 4.1.1 Prothromplex
  3. 4.1.2 Profilnine
  4. 4.1.3 Octaplex
  5. 4.1.4 Cofact
  6. 4.1.5 Beriplex
  7. 4.1.6 Other
  8. 4.2 Global Factor IX Complex Drug Sales Volume by Type
  9. 4.2.1 Global Factor IX Complex Drug Sales Volume by Type (2021 VS 2025 VS 2032)
  10. 4.2.2 Global Factor IX Complex Drug Sales Volume by Type (2021-2032)
  11. 4.2.3 Global Factor IX Complex Drug Sales Volume Share by Type (2021-2032)
  12. 4.3 Global Factor IX Complex Drug Sales Value by Type
  13. 4.3.1 Global Factor IX Complex Drug Sales Value by Type (2021 VS 2025 VS 2032)
  14. 4.3.2 Global Factor IX Complex Drug Sales Value by Type (2021-2032)
  15. 4.3.3 Global Factor IX Complex Drug Sales Value Share by Type (2021-2032)
5 Factor IX Complex Drug Market by Application
  1. 5.1 Factor IX Complex Drug Application Introduction
  2. 5.1.1 Hemophilia B
  3. 5.1.2 Acquired Coagulation Factor Deficiency
  4. 5.2 Global Factor IX Complex Drug Sales Volume by Application
  5. 5.2.1 Global Factor IX Complex Drug Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Factor IX Complex Drug Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Factor IX Complex Drug Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Factor IX Complex Drug Sales Value by Application
  9. 5.3.1 Global Factor IX Complex Drug Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Factor IX Complex Drug Sales Value by Application (2021-2032)
  11. 5.3.3 Global Factor IX Complex Drug Sales Value Share by Application (2021-2032)
6 Factor IX Complex Drug Regional Sales and Value Analysis
  1. 6.1 Global Factor IX Complex Drug Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Factor IX Complex Drug Sales by Region (2021-2032)
  3. 6.2.1 Global Factor IX Complex Drug Sales by Region: 2021-2026
  4. 6.2.2 Global Factor IX Complex Drug Sales by Region (2027-2032)
  5. 6.3 Global Factor IX Complex Drug Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Factor IX Complex Drug Sales Value by Region (2021-2032)
  7. 6.4.1 Global Factor IX Complex Drug Sales Value by Region: 2021-2026
  8. 6.4.2 Global Factor IX Complex Drug Sales Value by Region (2027-2032)
  9. 6.5 Global Factor IX Complex Drug Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Factor IX Complex Drug Sales Value (2021-2032)
  12. 6.6.2 North America Factor IX Complex Drug Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Factor IX Complex Drug Sales Value (2021-2032)
  15. 6.7.2 Europe Factor IX Complex Drug Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Factor IX Complex Drug Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Factor IX Complex Drug Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Factor IX Complex Drug Sales Value (2021-2032)
  21. 6.9.2 South America Factor IX Complex Drug Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Factor IX Complex Drug Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Factor IX Complex Drug Sales Value Share by Country, 2025 VS 2032
7 Factor IX Complex Drug Country-level Sales and Value Analysis
  1. 7.1 Global Factor IX Complex Drug Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Factor IX Complex Drug Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Factor IX Complex Drug Sales by Country (2021-2032)
  4. 7.3.1 Global Factor IX Complex Drug Sales by Country (2021-2026)
  5. 7.3.2 Global Factor IX Complex Drug Sales by Country (2027-2032)
  6. 7.4 Global Factor IX Complex Drug Sales Value by Country (2021-2032)
  7. 7.4.1 Global Factor IX Complex Drug Sales Value by Country (2021-2026)
  8. 7.4.2 Global Factor IX Complex Drug Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Factor IX Complex Drug Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Factor IX Complex Drug Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Factor IX Complex Drug Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Factor IX Complex Drug Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Factor IX Complex Drug Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Factor IX Complex Drug Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Factor IX Complex Drug Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Factor IX Complex Drug Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Factor IX Complex Drug Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Factor IX Complex Drug Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Factor IX Complex Drug Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Factor IX Complex Drug Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Factor IX Complex Drug Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Factor IX Complex Drug Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Factor IX Complex Drug Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Factor IX Complex Drug Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Factor IX Complex Drug Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Factor IX Complex Drug Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Factor IX Complex Drug Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Factor IX Complex Drug Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Factor IX Complex Drug Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Factor IX Complex Drug Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Factor IX Complex Drug Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Factor IX Complex Drug Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Factor IX Complex Drug Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Factor IX Complex Drug Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Factor IX Complex Drug Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Factor IX Complex Drug Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Factor IX Complex Drug Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Factor IX Complex Drug Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Factor IX Complex Drug Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Factor IX Complex Drug Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Factor IX Complex Drug Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Factor IX Complex Drug Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Factor IX Complex Drug Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Factor IX Complex Drug Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Factor IX Complex Drug Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Factor IX Complex Drug Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Factor IX Complex Drug Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Factor IX Complex Drug Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Factor IX Complex Drug Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Factor IX Complex Drug Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Factor IX Complex Drug Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Factor IX Complex Drug Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Factor IX Complex Drug Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Factor IX Complex Drug Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Factor IX Complex Drug Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Factor IX Complex Drug Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Factor IX Complex Drug Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Factor IX Complex Drug Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Factor IX Complex Drug Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Factor IX Complex Drug Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Factor IX Complex Drug Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Factor IX Complex Drug Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Factor IX Complex Drug Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Factor IX Complex Drug Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Factor IX Complex Drug Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Factor IX Complex Drug Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Factor IX Complex Drug Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Factor IX Complex Drug Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Factor IX Complex Drug Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Factor IX Complex Drug Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Factor IX Complex Drug Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Factor IX Complex Drug Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Factor IX Complex Drug Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Factor IX Complex Drug Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Factor IX Complex Drug Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Factor IX Complex Drug Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Factor IX Complex Drug Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Factor IX Complex Drug Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Factor IX Complex Drug Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Factor IX Complex Drug Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Factor IX Complex Drug Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Factor IX Complex Drug Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Factor IX Complex Drug Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Factor IX Complex Drug Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Factor IX Complex Drug Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Factor IX Complex Drug Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Factor IX Complex Drug Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Factor IX Complex Drug Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Factor IX Complex Drug Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Factor IX Complex Drug Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Factor IX Complex Drug Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Factor IX Complex Drug Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Takeda
  2. 8.1.1 Takeda Company Information
  3. 8.1.2 Takeda Business Overview
  4. 8.1.3 Takeda Factor IX Complex Drug Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Takeda Factor IX Complex Drug Product Portfolio
  6. 8.1.5 Takeda Recent Developments
  7. 8.2 Grifols
  8. 8.2.1 Grifols Company Information
  9. 8.2.2 Grifols Business Overview
  10. 8.2.3 Grifols Factor IX Complex Drug Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Grifols Factor IX Complex Drug Product Portfolio
  12. 8.2.5 Grifols Recent Developments
  13. 8.3 Prothya Biosolutions
  14. 8.3.1 Prothya Biosolutions Company Information
  15. 8.3.2 Prothya Biosolutions Business Overview
  16. 8.3.3 Prothya Biosolutions Factor IX Complex Drug Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Prothya Biosolutions Factor IX Complex Drug Product Portfolio
  18. 8.3.5 Prothya Biosolutions Recent Developments
  19. 8.4 Octapharma
  20. 8.4.1 Octapharma Company Information
  21. 8.4.2 Octapharma Business Overview
  22. 8.4.3 Octapharma Factor IX Complex Drug Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Octapharma Factor IX Complex Drug Product Portfolio
  24. 8.4.5 Octapharma Recent Developments
  25. 8.5 CSL Behring
  26. 8.5.1 CSL Behring Company Information
  27. 8.5.2 CSL Behring Business Overview
  28. 8.5.3 CSL Behring Factor IX Complex Drug Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 CSL Behring Factor IX Complex Drug Product Portfolio
  30. 8.5.5 CSL Behring Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Factor IX Complex Drug Value Chain Analysis
  2. 9.1.1 Factor IX Complex Drug Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Factor IX Complex Drug Sales Mode & Process
  6. 9.2 Factor IX Complex Drug Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Factor IX Complex Drug Distributors
  9. 9.2.3 Factor IX Complex Drug Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst